BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 17283199)

  • 1. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America.
    McCollum AM; Mueller K; Villegas L; Udhayakumar V; Escalante AA
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2085-91. PubMed ID: 17283199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
    Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from central Africa.
    McCollum AM; Basco LK; Tahar R; Udhayakumar V; Escalante AA
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4089-97. PubMed ID: 18765692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya.
    McCollum AM; Schneider KA; Griffing SM; Zhou Z; Kariuki S; Ter-Kuile F; Shi YP; Slutsker L; Lal AA; Udhayakumar V; Escalante AA
    Malar J; 2012 Mar; 11():77. PubMed ID: 22439637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
    Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
    Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia.
    Al-Farsi HM; Al-Hashami ZS; Bin Dajem SM; Al-Sheikh AA; Al-Qahtani A; Beja-Pereira A; Idris MA; Babiker HA
    Infect Genet Evol; 2012 Aug; 12(6):1253-9. PubMed ID: 22709478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites.
    Nzila AM; Mberu EK; Sulo J; Dayo H; Winstanley PA; Sibley CH; Watkins WM
    Antimicrob Agents Chemother; 2000 Apr; 44(4):991-6. PubMed ID: 10722502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
    Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
    Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
    J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi.
    Artimovich E; Schneider K; Taylor TE; Kublin JG; Dzinjalamala FK; Escalante AA; Plowe CV; Laufer MK; Takala-Harrison S
    J Infect Dis; 2015 Sep; 212(5):694-701. PubMed ID: 25672905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
    Plowe CV; Cortese JF; Djimde A; Nwanyanwu OC; Watkins WM; Winstanley PA; Estrada-Franco JG; Mollinedo RE; Avila JC; Cespedes JL; Carter D; Doumbo OK
    J Infect Dis; 1997 Dec; 176(6):1590-6. PubMed ID: 9395372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
    Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
    Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
    Bwijo B; Kaneko A; Takechi M; Zungu IL; Moriyama Y; Lum JK; Tsukahara T; Mita T; Takahashi N; Bergqvist Y; Björkman A; Kobayakawa T
    Acta Trop; 2003 Mar; 85(3):363-73. PubMed ID: 12659974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania.
    Pearce RJ; Drakeley C; Chandramohan D; Mosha F; Roper C
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1347-54. PubMed ID: 12654669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
    Oguike MC; Falade CO; Shu E; Enato IG; Watila I; Baba ES; Bruce J; Webster J; Hamade P; Meek S; Chandramohan D; Sutherland CJ; Warhurst D; Roper C
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):220-229. PubMed ID: 27821281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotypes associated with resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum in two malaria endemic locations in Colombia.
    Hernández DC; Guerra AP; Cucunubá ZM; Nicholls RS; Barrera SM
    Infect Genet Evol; 2013 Aug; 18():183-90. PubMed ID: 23714094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance.
    Ahmed A; Bararia D; Vinayak S; Yameen M; Biswas S; Dev V; Kumar A; Ansari MA; Sharma YD
    Antimicrob Agents Chemother; 2004 Mar; 48(3):879-89. PubMed ID: 14982779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru.
    Zhou Z; Griffing SM; de Oliveira AM; McCollum AM; Quezada WM; Arrospide N; Escalante AA; Udhayakumar V
    Antimicrob Agents Chemother; 2008 Feb; 52(2):739-41. PubMed ID: 18025120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.